AstraZeneca COVID-19 vaccine study paused after one illness
Reflections are seen in the sign on the global headquarters of Astra Zeneca in London, Thursday, Jan. 29, 2009. Pharmaceuticals company AstraZeneca PLC on Thursday reported a small drop in fourth-quarter net income and said it would cut a further 6,000 jobs globally by 2013 as it looks to shore up its earnings. (AP Photo/Kirsty Wigglesworth)
Array
